Scopus BioPharma Inc.
SCPSOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$25250
P/E Ratio—
52W High$0.01
52W Low$0.0003
Scopus BioPharma Inc. (SCPS) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
SCPS · earnings · updated Jun 9, 2026
Latest Earnings
Q3 FY2023Report Date: Aug 11, 2023EPS Actual
-$0.07
Revenue
—
Fiscal Period
Q3 FY2023
FY ends December
Report Date
Aug 11, 2023
After Market Close
✓ 1-Quarter EPS Beat Streak
SCPS reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Sep 2, 2026 | -$0.23 | — | — | — | — | — |
| ◌ Q2 FY2026 | Jun 3, 2026 | -$0.23 | — | — | — | — | — |
| ◌ Q2 FY2026 | Jun 3, 2026 | — | — | — | — | — | — |
| ◌ Q1 FY2026 | Feb 25, 2026 | -$0.22 | — | — | — | — | — |
| — Q3 FY2023 | Aug 11, 2023 | — | -$0.07 | — | — | — | — |
| — Q2 FY2023 | May 12, 2023 | — | -$0.08 | — | — | — | — |
| — Q4 FY2022 | Dec 31, 2022 | — | -$0.08 | — | — | — | — |
| — Q3 FY2022 | Sep 30, 2022 | — | -$0.09 | — | — | — | — |
Q3 FY2026
Sep 2, 2026
EPS Actual
—
EPS Est.
-$0.23
EPS Surpr.
—
Revenue
—
Q2 FY2026
Jun 3, 2026
EPS Actual
—
EPS Est.
-$0.23
EPS Surpr.
—
Revenue
—
Q2 FY2026
Jun 3, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2026
Feb 25, 2026
EPS Actual
—
EPS Est.
-$0.22
EPS Surpr.
—
Revenue
—
Q3 FY2023
Aug 11, 2023
EPS Actual
-$0.07
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2023
May 12, 2023
EPS Actual
-$0.08
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2022
Dec 31, 2022
EPS Actual
-$0.08
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2022
Sep 30, 2022
EPS Actual
-$0.09
EPS Est.
—
EPS Surpr.
—
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2027 | $-0.07 | $-0.07 | $-0.07 | 1 |
| Q4 FY2026 | $-0.07 | $-0.07 | $-0.07 | 1 |
| Q3 FY2026 | $-0.23 | $-0.23 | $-0.23 | 1 |
| Q2 FY2026 | $-0.23 | $-0.23 | $-0.23 | 1 |
| Q1 FY2026 | $-0.22 | $-0.22 | $-0.22 | 1 |
| Q4 FY2025 | $-0.22 | $-0.22 | $-0.22 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q3 FY2023 | Aug 11, 2023 | — | $0.06 | $0.05 | -14.04% |
| — Q2 FY2023 | May 12, 2023 | — | $0.07 | $0.07 | +0.00% |
| — Q4 FY2022 | Dec 31, 2022 | — | $0.10 | $0.10 | +2.04% |
| — Q3 FY2022 | Sep 30, 2022 | — | $0.24 | $0.24 | +1.26% |
| — Q2 FY2022 | Jun 30, 2022 | — | $0.38 | $0.43 | +14.06% |
| — Q4 FY2021 | Dec 31, 2021 | — | $1.63 | $1.64 | +0.61% |
| ▲ Q4 FY2021 | Nov 12, 2021 | +65.2% | $3.42 | $3.49 | +2.05% |
| ▼ Q3 FY2021 | Aug 13, 2021 | -321.7% | $4.97 | $4.53 | -8.85% |
Q3 FY2023-14.04%
Report Date
Aug 11, 2023
EPS Beat/Miss
—
Price Before
$0.06
Price After
$0.05
Q2 FY2023+0.00%
Report Date
May 12, 2023
EPS Beat/Miss
—
Price Before
$0.07
Price After
$0.07
Q4 FY2022+2.04%
Report Date
Dec 31, 2022
EPS Beat/Miss
—
Price Before
$0.10
Price After
$0.10
Q3 FY2022+1.26%
Report Date
Sep 30, 2022
EPS Beat/Miss
—
Price Before
$0.24
Price After
$0.24
Q2 FY2022+14.06%
Report Date
Jun 30, 2022
EPS Beat/Miss
—
Price Before
$0.38
Price After
$0.43
Q4 FY2021+0.61%
Report Date
Dec 31, 2021
EPS Beat/Miss
—
Price Before
$1.63
Price After
$1.64
Q4 FY2021+2.05%
Report Date
Nov 12, 2021
EPS Beat/Miss
+65.2%
Price Before
$3.42
Price After
$3.49
Q3 FY2021-8.85%
Report Date
Aug 13, 2021
EPS Beat/Miss
-321.7%
Price Before
$4.97
Price After
$4.53
Avg Beat Reaction+2.05%
Avg Miss Reaction-8.85%
Beat Rate1 / 8 quarters
Largest Move+14.06% (Q2 FY2022)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: SCPS ends December
Scopus BioPharma Inc. (SCPS) most recently reported earnings on August 11, 2023 for Q3 FY2023, posting EPS of $-0.07 (in line with the analyst consensus of —). The next SCPS earnings date is expected around September 1, 2026.
Each quarter, investors track SCPS earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. SCPS revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
SCPS's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
SCPS earnings · 4 questionsScopus BioPharma Inc.'s next earnings report is expected around September 1, 2026. SCPS typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; SCPS historically reports after market close (AMC).
SCPS earnings datewhen is SCPS earningsSCPS next earnings datewhen does SCPS report earningsSCPS earnings calendar
▸ Source: FMP · Scopus BioPharma Inc. SEC filings · US GAAP · Scopus BioPharma Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026